186 related articles for article (PubMed ID: 30303650)
41. [Effect of vitamin D receptor activators on serum Klotho levels in 3b-4 stages chronic кidney disease patients: a prospective randomized study].
Milovanova LY; Beketov VD; Milovanova SY; Taranova MV; Kozlov VV; Pasechnik AI; Reshetnikov VA; Androsova TV; Kalashnikov MV
Ter Arkh; 2021 Jun; 93(6):679-684. PubMed ID: 36286834
[TBL] [Abstract][Full Text] [Related]
42. Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.
Kanda E; Ai M; Okazaki M; Yoshida M; Maeda Y
PLoS One; 2016; 11(11):e0166459. PubMed ID: 27861640
[TBL] [Abstract][Full Text] [Related]
43. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
[TBL] [Abstract][Full Text] [Related]
44. Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.
Shroff R; Aitkenhead H; Costa N; Trivelli A; Litwin M; Picca S; Anarat A; Sallay P; Ozaltin F; Zurowska A; Jankauskiene A; Montini G; Charbit M; Schaefer F; Wühl E;
J Am Soc Nephrol; 2016 Jan; 27(1):314-22. PubMed ID: 26069294
[TBL] [Abstract][Full Text] [Related]
45. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
[TBL] [Abstract][Full Text] [Related]
46. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
Silva AP; Mendes F; Carias E; Gonçalves RB; Fragoso A; Dias C; Tavares N; Café HM; Santos N; Rato F; Leão Neves P; Almeida E
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934737
[TBL] [Abstract][Full Text] [Related]
47. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.
Akimoto T; Yoshizawa H; Watanabe Y; Numata A; Yamazaki T; Takeshima E; Iwazu K; Komada T; Otani N; Morishita Y; Ito C; Shiizaki K; Ando Y; Muto S; Kuro-o M; Kusano E
BMC Nephrol; 2012 Nov; 13():155. PubMed ID: 23176706
[TBL] [Abstract][Full Text] [Related]
48. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
[TBL] [Abstract][Full Text] [Related]
49. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
Sawires HK; Essam RM; Morgan MF; Mahmoud RA
Nephron; 2015; 129(4):293-9. PubMed ID: 25766835
[TBL] [Abstract][Full Text] [Related]
50. Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.
Misra S; Khosla A; Allred J; Harmsen WS; Textor SC; McKusick MA
J Vasc Interv Radiol; 2016 Aug; 27(8):1215-24. PubMed ID: 27296703
[TBL] [Abstract][Full Text] [Related]
51. Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During Hemodialysis.
Marçais C; Maucort-Boulch D; Drai J; Dantony E; Carlier MC; Blond E; Genet L; Kuentz F; Lataillade D; Legrand E; Moreau-Gaudry X; Jean G; Fouque D;
J Clin Endocrinol Metab; 2017 Sep; 102(9):3154-3161. PubMed ID: 28402487
[TBL] [Abstract][Full Text] [Related]
52. FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease.
Ribeiro AL; Mendes F; Carias E; Rato F; Santos N; Neves PL; Silva AP
J Diabetes Complications; 2020 Jan; 34(1):107476. PubMed ID: 31708378
[TBL] [Abstract][Full Text] [Related]
53. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
[TBL] [Abstract][Full Text] [Related]
54. Effect of essential amino acid кetoanalogues and protein restriction diet on morphogenetic proteins (FGF-23 and Кlotho) in 3b-4 stages chronic кidney disease patients: a randomized pilot study.
Milovanova L; Fomin V; Moiseev S; Taranova M; Milovanov Y; Lysenko Kozlovskaya L; Kozlov V; Kozevnikova E; Milovanova S; Lebedeva M; Reshetnikov V
Clin Exp Nephrol; 2018 Dec; 22(6):1351-1359. PubMed ID: 29948444
[TBL] [Abstract][Full Text] [Related]
55. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
56. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.
Liu Y; Ma X; Zheng J; Jia J; Yan T
BMC Nephrol; 2017 Jun; 18(1):206. PubMed ID: 28666408
[TBL] [Abstract][Full Text] [Related]
57. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.
Catalá-López F; Macías Saint-Gerons D; González-Bermejo D; Rosano GM; Davis BR; Ridao M; Zaragoza A; Montero-Corominas D; Tobías A; de la Fuente-Honrubia C; Tabarés-Seisdedos R; Hutton B
PLoS Med; 2016 Mar; 13(3):e1001971. PubMed ID: 26954482
[TBL] [Abstract][Full Text] [Related]
58. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
[TBL] [Abstract][Full Text] [Related]
59. Hypertension Management in Transition: From CKD to ESRD.
Valika A; Peixoto AJ
Adv Chronic Kidney Dis; 2016 Jul; 23(4):255-61. PubMed ID: 27324679
[TBL] [Abstract][Full Text] [Related]
60. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
